Estimation of self‐funded human papillomavirus vaccine recipients from Japan's previously assumed “unvaccinated generation”

Author:

Kobayashi Mariya1ORCID,Nakagawa Satoshi1ORCID,Ueda Yutaka1ORCID,Yagi Asami1ORCID,Kakuda Mamoru1ORCID,Hiramatsu Kosuke1ORCID,Kimura Tadashi1ORCID

Affiliation:

1. Department of Obstetrics and Gynecology, Graduate School of Medicine The University of Osaka Suita‐City, Osaka Japan

Abstract

AbstractPrecise vaccination data is essential to accurately estimate the effectiveness of the human papillomavirus (HPV) vaccine against HPV‐related cancers. In Japan, the number of subsidized HPV vaccinations can be tracked through registries, but the number of self‐funded vaccinations has not been tracked. The number of individuals who chose to receive the vaccine at their own expense, despite being ineligible for public subsidies due to their age, is unknown and has been nominally considered to be zero. Our aim is to produce a more accurate estimate of this number using recently released proprietary data. First, we estimated the total number of self‐funded HPV vaccinations occurring from 2010 to 2012 using public data from the Ministry of Health, Labour and Welfare and our previously reported data on the number of HPV vaccinations eligible for public subsidy. Second, using proprietary data from the vaccine manufacturer, we calculated the distribution of self‐funded vaccination shots by age. Finally, we combined these data to estimate the number of self‐funded HPV vaccinations by birth fiscal year (FY) relative to a yearly reference population. We found that 78,264 individuals born in FY1993 and 58,190 born in FY1992 self‐funded their vaccinations, representing 13.6% and 10.0% of the reference population, respectively. Additionally, we found that 5%–10% of individuals born from FY1986 to FY1991 self‐funded their vaccinations. Our study revealed for the first time that a certain number of individuals from the “HPV unvaccinated generation,” ineligible for subsidies due to age restrictions, chose to self‐fund their vaccinations.

Publisher

Wiley

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3